Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Intas finalises corporate plans post IPO
Focuses on European market and setting up of a new R&D centre in Ahmedabad
IMA opposes proposed one year pharmacology course for non MBBS doctors
Alleges that the real problem is infrastructure not availability of doctors
Piramal healthcare vertical invests $2.5 million to further expand commercial ADC capacity
The upgrade will give Piramal two commercial grade ADC suites at the Grangemouth facility
Strides Arcolab posts consolidated revenues of Rs 464 crores in H1’13
In Q2' 13, the company posts consolidated revenues of Rs 228 crores
Zydus and IDRI sign agreement
Zydus & IDRI will collaborate to conduct clinical development activities in India for visceral leishmaniasis (Kala-Azar)
Biocon posts growth of 22 per cent driven by strong traction in biopharma
Revenues at Rs 723 crores; EBITDA at Rs 175 crores; PAT at Rs 94 crores
Viral hepatitis: The era of molecular assays
Dr Faisal Khan, Sr Research Officer-Knowledge Management R&D, SRL gives an outlook on the burgeoning morbidity and mortality…
Phenomenex Phree Phospholipid Removal Plates wins R&D 100 award
This is the ninth Phenomenex product to receive this award in the last 10 years
Jamshedpur, Delhi, Mangalore students excel; among top three at Novartis Biotechnology Leadership…
To represent India at International BioCamp in Basle, Switzerland
Lupin receives FDA approval for Generic Glumetza extended-release tabs
Is indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type II diabetes mellitus